Cellular potassium gradient ([K+] gradient)

The cellular potassium gradient represents the significant concentration difference of potassium ions across the cell membrane, maintained primarily by the active transport of the Na+/K+-ATPase pump (StatPearls: Physiology, Potassium, 2023). This gradient is fundamental to the physiological function of excitable tissues, as it dictates the resting membrane potential and enables the repolarization phase of action potentials in the heart and nervous system (Molecular Biology of the Cell, 2002). Under normal conditions, intracellular potassium is high (~150 mM) while extracellular levels are low (~4 mM), a balance critical for cellular volume regulation and enzyme function (NIH: Potassium, 2022). Disruptions to this gradient, known as hyperkalemia or hypokalemia, can lead to life-threatening complications such as cardiac arrhythmias, muscle paralysis, and metabolic disturbances (Mayo Clinic: Hyperkalemia, 2023). While the gradient itself is a physiological state rather than a single protein, it is the functional target of numerous drugs, including diuretics, potassium supplements, and ion channel modulators (British Journal of Pharmacology, 2006). Management of the potassium gradient is a cornerstone of treatment in renal failure, heart failure, and hypertension (American Journal of Kidney Diseases, 2017).

Other names

Transmembrane potassium gradientIntracellular-extracellular potassium ratioPotassium concentration gradientK+ gradient

Drugs modulate the gradient by inhibiting or activating potassium-selective ion channels, inhibiting the Na+/K+-ATPase pump, altering renal tubular secretion/reabsorption, or inducing intracellular ion shifts.